Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.

计划入组 52 人 · 首次发布于 2015 年 2 月 6 日

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

计划入组 50 人 · 首次发布于 2010 年 9 月 16 日

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

计划入组 17 人 · 首次发布于 2020 年 7 月 21 日

Anti-blood-brain barrier/CNS bispecific antibody (AB Studio)

PAT-CM-2

PAT-BA-1

Cambridge Antibody Technology

New Zealand

Latticon Antibody Therapeutics, Inc

United States

EicOsis Human Health, Inc.

United States

AlivaMab Biologics Offers Royalty-Free Access to Transgenic Mouse Platform for Human Antibody Discovery

Biocytogen Secures Japan Patent for RenMab Platform, Strengthening Global IP Portfolio for Fully Human Antibody Discovery

International Consortium Develops Revolutionary Platform to Predict Human Antibody Drug Responses